Article ID Journal Published Year Pages File Type
5583086 Journal of Clinical Anesthesia 2017 5 Pages PDF
Abstract
Ketorolac 30 mg intravenous was not superior to 15 mg intravenous for post-operative pain management after spine surgery. However, 15 mg failed to meet the pre-specified criteria for non-inferiority to the 30 mg dose.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Anesthesiology and Pain Medicine
Preview
Intraoperative ketorolac dose of 15 mg versus the standard 30 mg on early postoperative pain after spine surgery: A randomized, blinded, non-inferiority trial
Authors
, , , , , , ,